We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Spells Out Plans to Encourage Advanced Therapy Drug Products
EMA Spells Out Plans to Encourage Advanced Therapy Drug Products
The European Medicines Agency issued an updated action plan to encourage advanced therapy medicinal products (ATMPs) — including the release by year’s end of draft guidelines for clinical trial sponsors.